Clinical Trial: The Effect of AMG 133 on Gastric Emptying

U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07429032) titled 'The Effect of AMG 133 on Gastric Emptying' on Feb. 18.

Brief Summary: The primary objective of the trial is to evaluate the effect of AMG 133 versus placebo on acetaminophen pharmacokinetics (PK), a marker for gastric emptying, in participants living with overweight or obesity.

Study Start Date: April 17, 2025

Study Type: INTERVENTIONAL

Condition: Overweight or Obesity

Intervention: DRUG: AMG 133

AMG 133 will be administered SC.

DRUG: Placebo

Placebo will be administered SC.

DRUG: Acetaminophen

Acetaminophen will be administered orally.

Recruitment Status: COMPLETED

Sponsor: Amgen

Published by HT Digital Content Servic...